Home > > > > > Report Detail

Asia-Pacific Ophthalmic Drugs & Devices Market Forecast 2017-2025

Publisher Name :
Date: 01-Jun-2017
No. of pages: 78

Key Findings

Asia Pacific ophthalmic drugs & devices market was valued at $11815.02 million in 2016 and is expected to reach $20920.43 million by 2025 growing at a CAGR of 6.64% during the forecast period of 2017-2025. The ophthalmic drugs and devices market is driven by an increase in FDA approvals which gives a boost in the adoption of drugs and devices and rise in surgeries in ophthalmology market due to the high dominance of refractive errors.

Market Insights

The Asia-Pacific ophthalmic drugs & devices market is segmented by ophthalmic devices, surgery devices, vision care, by type of diseases, by therapeutics and by geography atrophy. increase in geriatric population globally, rise in the number of eye disorders, increase in healthcare expenditure and rise in adoption of minimally invasive surgeries have contributed to the growth of the market.

Well-known drugs are going off patent and key players affected by the delay in new drugs coming into the market are the two factors restricting the growth of the market. The market faces challenges in risk associated with the ocular diseases and lack of awareness among people regarding ophthalmology.

Competitive Insights

Global ophthalmic drugs market has a large number of market players but the market is dominated by companies like Novartis AG and Santen.

Asia-Pacific Ophthalmic Drugs & Devices Market Forecast 2017-2025

Table of Contents

1 Research Scope
1.1 Study Goals
1.2 Scope of Market Study
1.3 Who Will Find This Report Useful?
1.4 Study and Forecasting Years
2 Research Methodology
2.1 Sources of Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Top Down Approach
2.3 Bottom-Up Approach
2.4 Data Triangulation
3 Executive Summary
3.1 Key Findings
4 Market Overview
4.1 Market Definition and Scope
4.2 Top Ophthalmic Drugs Brands
5 Market Determinants
5.1 Market Drivers
5.1.1 Increasing Fda Approvals Giving A Boost To Adoption of Drugs and Devices
5.1.2 Surgeries In Ophthalmology Market On Rise Due To High Prevalence Rate of Refractive Errors
5.1.3 Increasing Geriatric Population Globally
5.1.4 Rising Prevalence of Eye Disorders
5.1.5 Increased Healthcare Expenditure
5.1.6 Minimally Invasive Surgeries Adoption On Rise
5.2 Market Restraints
5.2.1 Renowned Drugs Going Off Patent
5.2.2 Major Players Affected By Drying Pipelines
5.3 Market Opportunities
5.3.1 Growing Opportunities In Developing Economies
5.3.2 Emerging Markets Present Remarkable Growth Opportunities
5.4 Market Challenges
5.4.1 Risk Associated With the Ocular Diseases
5.4.2 Lack of Awareness
6 Market Segmentation
6.1 By Ophthalmic Devices
6.1.1 Diagnostic & Monitoring Equipment
6.1.1.1 Optical Coherence Tomography Scanners
6.1.1.2 Ophthalmic Ultra Sound Imaging Systems
6.1.1.3 Fundus Camera
6.1.1.4 Ophthalmoscopes
6.1.1.5 Retinoscope
6.1.1.6 Pachymeter
6.1.1.7 Wavefront Aberrometers
6.1.1.8 Perimeters/Visual Field Analyzer
6.1.1.9 Autorefractors/Phoropter
6.1.1.10 Keratometers
6.1.1.11 Specular Microscope
6.1.1.12 Corneal Topoghaphers
6.1.1.13 Tonometers
6.1.1.14 Slit Lamps
6.1.1.15 Biometers
6.1.1.16 Other
6.1.2 Surgery Device
6.1.2.1 Cataract Surgery Device
6.1.2.1.1 Intraocular Lens
6.1.2.1.2 Phacoemulsification Devices
6.1.2.1.3 Ophthalmic Viscoelastic Devices
6.1.2.2 Glaucoma Surgery Device
6.1.2.2.1 Stents and Implant
6.1.2.2.2 Glaucoma Drainage Device
6.1.2.2.3 Glaucoma System
6.1.2.2.4 Glaucoma Laser
6.1.2.3 Refractive Surgery Device
6.1.2.3.1excimer Laser
6.1.2.3.2 Emcrokeratome
6.1.2.3.3 Femtosecond Laser
6.1.2.3.4 Yag Laser
6.1.2.4 Vitreoretinal Surgery Device
6.1.2.4.1photocoagulation Laser
6.1.2.4.2 Illumination Device
6.1.2.4.3 Vitrectomy Machine
6.2 By Vision Care
6.2.1 Contact Lens
6.2.2 Spectacles
6.2.3 Eye Exams
6.3 By Ophthalmic Drugs
6.3.1 By Prescription Type
6.3.1.1 Prescription Based Ophthalmic Drugs
6.3.1.2 Otc (Over the Counter Drugs)
6.3.2 By Drug Delivery Types
6.3.2.1 Eye Drops
6.3.2.2 Capsules & Tablet
6.3.2.3 Eye Ointment
6.3.2.4 Eye Gel
6.3.2.5 Eye Solution
6.4 By Type of Disease
6.4.1 Glaucoma
6.4.1.1 Xalatan (Latanoprost)/Xalacom (Latanoprost and Timolol Combination) (Xalabrands)
6.4.1.2 Lumigan Franchise [Lumigan (Bimatoprost) + Ganfort (Bimatoprost and Timolol Combination)]
6.4.1.3 Tapros/Taflotan (Tafluprost)
6.4.1.4 Saflutan/Zioptan (Tafluprost)
6.4.1.5 Alphagan (Brimonidine)/Combigan (Brimonidine and Timolol Combination)
6.4.1.6 Cosopt (Dorzolamide and Timolol Combination)/ Trusopt (Dorzolamide)
6.4.1.7 Azarga (Brinzolamide and Timolol Combination)
6.4.1.8 Azopt (Brinzolamide)
6.4.2 Retinal Disorder
6.4.2.1 Lucentis (Ranibizumab)
6.4.2.2 Visudyne (Verteporfin)
6.4.2.3 Avastin (Bevacizumab)
6.4.2.4 Eylea (Aflibercept)
6.4.3 Dry Eye Drug
6.4.3.1 Restasis (Cyclosporine)
6.4.3.2 Hyalein (Sodium Hyaluronate)
6.4.3.3 Diquas (Diquafosol Sodium)
6.4.4 Allergic Conjunctivitis, Inflammation and Conjunctivitis Drugs
6.4.4.1 Patanol/Pataday/Opatanol (Olopatadine)
6.4.4.2 Bepreve (Bepotastine Besilate)
6.4.4.3 Tobradex (Tobramycin & Dexamethasone Combination)
6.4.4.4 Xibrom/Bromday (Bromfenac)
6.4.4.5 Vigamox
6.4.4.6 Azasite (Azithromycin)
6.5 By Therapeutics
6.5.1 Diabetic Macular Edema
6.5.2 Eye Cancer
6.5.3 Diabetic Retinopathy
6.5.4 Retinal Vein Occlusion
6.5.5 Age-Related Macular Degeneration
6.5.6 Conjunctivitis
6.5.7 Dry Eye
6.5.8 Glaucoma
6.5.9 Keratitis
6.5.10 Geographic Atrophy
6.6 By End User
6.6.1 Hospitals
6.6.2 Eye Clinics
6.6.3 Diagnostic Centers
6.6.4 Patients
7 Key Analytics
7.1 Porter's Five Force Analysis
7.1.1 Bargaining Power Buyers
7.1.2 Bargaining Power of Supplier
7.1.3 Threats of New Entarants
7.1.4 Threats of Substitutes
7.1.5 Competitive Rivalry
7.2 Value Chain Analysis
7.2.1 Suppliers
7.2.2 Manufacturers
7.2.3 Distributors and Retailers
7.2.4 End User
7.3 Key Buying Criteria
7.4 Key Market Insights
7.4.1 Top 3 Emerging Countries
7.4.2 Top Revenue Generating Segments
7.4.3 Top Growing Markets and Emerging Trends
7.4.4 R&D Scenario In Ophthalmology Market
7.4.4.1 Plasma Technology In Ophthalmology
7.4.4.2 Cornial Topography & Cornial Analysis
7.4.4.3 Scope of Virtual Reality Technology In Eye Care
7.5 Sector Analysis
7.5.1 Parent Market
7.5.2 Sub-Segment Market
7.5.3 Alternative Market
7.6 Strategic Recommendation
7.7 Strategic Conclusions
8 Geographic Analysis
8.1 Asia Pacific
8.1.1 India
8.1.2 China
8.1.3 Japan
8.1.4 South Korea
8.1.5 Australia
8.1.6 Roapac
9 Competitive Landscape
9.1 Market Share Analysis
9.2 Top Winning Strategies
9.3 Case Studies: Top Competitive Moves
9.4 Company Profiles
9.4.1 Abbott Laboratories
9.4.2 Akorn
9.4.3 Allergan Inc.
9.4.4 Bayer Ag
9.4.5 Cipla Pharmaceuticals
9.4.6 Eyegate Pharmaceuticals
9.4.7 Eyemed
9.4.8 Glaxosmithkline
9.4.9 Johnson and Johnson
9.4.10 Lpath Incorporated
9.4.11 Merck & Co.
9.4.12 Biotech Visioncare
9.4.13 Carl Zeiss Mediatek Ag
9.4.14 Ellex
9.4.15 Nidek Co. Ltd
9.4.16 Novartis Ag
9.4.17 Pfizer Inc.
9.4.18 Regeneron
9.4.19 Roche Holding Ag
9.4.20 Senju Pharmaceutical Co., Ltd
9.4.21 Sun Pharmaceuticals Industries, Ltd.
9.4.22 Santen Pharmaceutical Co.Ltd
9.4.23 Staar Surgical Company
9.4.24 Topcon Corporation
9.4.25 Valeant
9.4.26 Visioncare Ophthalmic Technologies
9.4.27 Ziemer Ophthalmic Systems Ag
9.4.28 Haag-Streit Group
9.4.29 Iridex Corporation

List of Tables
Table 1 Apac Ophthalmic Drugs and Device Market By Product 2017-2025 ($ Million)
Table 2 Top Ophthalmic Drugs Brands
Table 3 Drugs and Devices Approved By Fda
Table 4 Symptoms of Some Common Causes of Loss of Vision In Elderly Patients
Table 5 Eye Drugs Gone Patent Off
Table 6 Facts About Cataract Surgeries From Developing Economies
Table 7 Apac Ophthalmic Device Market By Geography 2017-2025($Million)
Table 8 Apac Ophthalmic Device Market 2017-2025 ($ Million)
Table 9 Apac Ophthalmic Diagnostic & Monitoring Equipment Market 2017-2025 ($ Million)
Table 10 Scans Performed By Domains
Table 11 Difference Between A-Scan and B-Scan Sound Waves Generation
Table 12 Comparison Between Direct and Indirect Ophthalmoscopy
Table 13 Apac Ophthalmic Surgery Device Market 2017-2025 ($ Million)
Table 14 Patent For Illumination System In Ophthalmic Surgery 2015
Table 15 Apac Vision Care Market By Device 2017-2025 ($ Million)
Table 16 Eye Exams Among Various Age Individuals
Table 17 Various Fda Approved Drugs For Ophthalmology
Table 18 Fda-Approved Prescription Drug Information
Table 19 Ophthalmic Drug Products For Over-The-Counter Human Use
Table 20 Apac Ophthalmology Drug Market By Delivery Types 2017-2025 ($ Million)
Table 21 Top Selling Eye Drops 2016
Table 22 Top Selling Eye Supplements Brands In Us In 2014
Table 23 Top Selling Eye Ointment In Us 2015
Table 24 Top Selling Eye Solution In Us 2015
Table 25 Apac Ophthalmic Drug and Device Market By Therapeutics 2017-2025 ($ Million)
Table 26 Symptoms, Treatment, and Recovery Time For Diabetic Macular Edema
Table 27 Symptoms and Treatment For Eye Cancer
Table 28 Apac Ophthalmic Drugs & Devices Market By End User 2017-2025 ($ Million)
Table 29 Application of Virtual Reality In Eye Care
Table 30 Case Study of Virtual Reality In Glaucoma Research
Table 31 Asia-Pacific Ophthalmic Drugs & Devices Market By Countries 2017-2025 ($ Million)
Table 32 Initiatives For Eye Care In Asia Pacific Region
Table 33 Personnel Needed For Eyecare In India
Table 34 Prevalence Rate of Eye Related Diseases In China 2014
Table 35 Eye Health Statistics In Australia
Table 36 Key Causes of Blindness In Indonesia
Table 37 Rest of Asia-Pacific Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)
Table 38 Top Winning Strategies

List of Figures
Figure 1 Key Findings of the Report
Figure 2 Projections For the Proportion of Global Geriatric (60+) Population
Figure 3 Worldwide Prevalence of Presbyopia (Billion)
Figure 4 Prevalence of Glaucoma At Global Level (Million)
Figure 5 Healthcare Expenditure of Developed Economies As % of Their Gdp In 2014
Figure 6 Healthcare Expenditure of Developing Economies As % of Their Gdp In 2014
Figure 7 Healthcare Expenditure (As % of Gdp) of Major Apac Countries In 2014
Figure 8 Growth In Geriatric Population From 2010 To 2015(%)
Figure 9 Risk Associated With the Ocular Diseases
Figure 10 Blindness Causes Worldwide
Figure 11 Apac Cataract Surgery Device Market 2017-2025 ($ Million)
Figure 12 Apac Glaucoma Surgery Device Market 2017-2025 ($ Million)
Figure 13 Apac Refractive Surgery Device Market 2017-2025 ($ Million)
Figure 14 Apac Vitreoretinal Surgery Device Market 2017-2025 ($ Million)
Figure 15 Apac Contact Lens Market 2017-2025 ($ Million)
Figure 16 Contact Lens Usage Among Various Age Groups In the U.S. 2015
Figure 17 Apac Spectacles Market 2017-2025 ($ Million)
Figure 18 Eye Exams In the U.S. Adults 2012-2014 (Million)
Figure 19 Consumption of Drugs By Types In 2016
Figure 20 Apac Eye Drops Market 2017-2025 ($ Million)
Figure 21 Usage of Eye Drops and Eye Wash In U.S. Households 2012-2015 (%)
Figure 22 Apac Capsules & Tablet Market 2017-2025 ($ Million)
Figure 23 Apac Eye Ointment Market 2017-2025 ($ Million)
Figure 24 Apac Eye Gel Market 2017-2025 ($ Million)
Figure 25 Apac Eye Solution Market 2017-2025 ($ Million)
Figure 26 Apac Glaucoma Drug Market 2017-2025 ($ Million)
Figure 27 Different Age Group With Probability of Being Affected 2016
Figure 28 Apac Retinal Disorder Drugs Market 2017-2025 ($ Million)
Figure 29 Apac Dry Eye Drug Market 2017-2025($ Million)
Figure 30 Apac Allergic Conjunctivitis, Inflammation and Conjunctivitis Drugs Market 2017-2025 ($ Million)
Figure 31 Diabetic Retinopathy Prevalence In the U.S. 2011 & 2030 (Million)
Figure 32 Total Ophthalmic Care Hospital In Us 2014
Figure 33 Eye Diseases Cases Above Age of 40 In America 2014 (Million)
Figure 34 Total Visual Impairment and Blindness Cases Above Age 40 In Us In 2014 (Million)
Figure 35 Cases Above 40 Age In America 2014 (Million)
Figure 36 Value Chain Analysis: Ophthalmic Drugs Market
Figure 37 Value Chain Analysis of Ophthalmic Devices Market
Figure 38 Key Buying Criteria
Figure 39 Key Buying Criteria Impact
Figure 40 Top Revenue Generating Segments 2017-2025 ($ Million)
Figure 41 Benefits Supporting Higher Cataract Surgeries
Figure 42 Major Research and Development Areas In Plasma Technology In Ophthalmology
Figure 43 Number of Clinics Using Vr Systems In Various Geographies
Figure 44 Key Market Facts
Figure 45 Vision Screening Performed By Each Group of Providers (In %)
Figure 46 Attractive Investment Proposition By Segment 2016 ($ Million)
Figure 47 Attractive Investment Proposition By Geography 2016 ($ Million)
Figure 48 Healthcare Expenditure In Asia-Pacific Countries
Figure 49 India Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)
Figure 50 China Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)
Figure 51 Geriatric Population In Japan (65 Years and Above) 2014 & 2060
Figure 52 Japan Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)
Figure 53 South Korea Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)
Figure 54 Causes of Blindness In Australia In 2016
Figure 55 Australia Ophthalmic Drugs & Devices Market 2017-2025 ($ Million)

  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs